$AU

AngloGold Ashanti ADR earnings missed by $0.06, revenue fell short of estimates

AngloGold Ashanti ADR (NYSE: AU) reported Q2 EPS of $1.98, missing the $2.04 analyst estimate by $0.06. Revenue was $3.19B, below the $3.3B consensus. The ADR closed at $82.33, down 9.22% over three months and up 68.85% over 12 months, according to Investing.com.

Original reporting
Published Jul 31, 2026, 12:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 1:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AU
Bearish
medium confidence
Mentioned
$AU
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AUBearishLow
01

Why it matters

A modest earnings miss can pressure near-term sentiment, but without guidance or balance-sheet changes it is less likely to drive a durable repricing.

02

Market read

Traders get a straightforward earnings miss datapoint (EPS and revenue) but no additional decision-grade catalyst like guidance, restructuring, or a major contract.

03

What to watch

No discussion of guidance, cost inflation, production volumes, or realized gold price, so traders may be over-weighting the headline miss without checking the earnings release details.

Relevance 4/10Novelty 4/10Timing: post-Q2 earnings report, same-day context

Background

The article frames AU’s Q2 results versus analyst consensus and adds performance stats over 3 and 12 months.

Company-level read

Ticker impact

$AUBearishMedium confidence
Context

AngloGold Ashanti ADR reported Q2 EPS of $1.98, missing the $2.04 estimate, and revenue of $3.19B vs $3.3B consensus.

Expected impact

Likely supports continued downside bias or elevated volatility around earnings, absent any new guidance or balance-sheet shock.

Evidence & confidence

The only concrete new facts are the reported EPS and revenue versus consensus; the rest is performance commentary and promotional framing without incremental fundamentals.

Market effects

Gold miners may see sentiment pressure when earnings miss on revenue and margins, but this article does not add sector-wide new data.

No specific regional market linkage beyond the issuer’s ADR trading.

Limited, as the piece does not introduce new macro gold-price or policy catalysts.

Counterpoint

The article notes a “Financial Health score is great performance” and AU is up strongly over 12 months, suggesting the miss may be partially priced and not a trend break.

Key entities

  • AngloGold Ashanti ADR

    Reports Q2 EPS and revenue that miss consensus estimates in the article.

Related articles

$AUMedAI 8/10

AngloGold Ashanti (AU) Q2 2026 Earnings Call Transcript

AngloGold Ashanti (AU) reported Q2 2026 results on an earnings call. Gold production fell 7% to 744,000 ounces. Basic EPS rose 49% to $1.97. EBITDA increased 46% to $1.97B and free cash flow rose 36% to $727M. The company reaffirmed 2026 production guidance of 2.8-3.17M ounces and AISC of $1,780-$1,990/oz, while targeting a net cash position near $1B and a $2B buyback.

$AUMed

AngloGold reports 58% rise in Q2 2026 headline earnings

AngloGold Ashanti reported Q2 2026 headline earnings of $1.0bn, up 58% from $639m a year earlier, driven by cost management and a 35% higher average gold price to $4,446/oz. EBITDA rose 46% to $2.0bn, free cash flow increased 36% to $727m, and it declared an interim dividend of $364m ($0.72/share).

$AUMed

AngloGold quarterly profit up 58% as higher bullion prices offset lower output

AngloGold Ashanti reported second-quarter profit up 58% to $1.01 billion, citing higher bullion prices offsetting lower output. Headline earnings rose from $639 million a year earlier. Gold production fell 7% to 744,000 ounces, with declines at Serra Grande and Obuasi. Free cash flow increased 36% to $727 million on a 35% higher average gold price. The company plans a $0.72 quarterly dividend and a $2 billion share buyback.

$AUMed

AngloGold Ashanti Q2 EPS misses estimate despite 46% EBITDA surge

AngloGold Ashanti reported Q2 2026 adjusted EPS of $1.98 versus a $2.18 estimate and sales of $3.034bn versus $3.194bn consensus, despite EBITDA rising 46% to $2.0bn. The company cited a 35% higher average gold price received to $4,446/oz, offset by higher cash costs and a 7% production decline. Analysts cut AU price targets to $125-$134.